Boulder, Colorado, June 27, 2018 (GLOBE NEWSWIRE) -- REACH Genetics, Inc., announced today that it has signed an agreement with the Asian American Trade Associations Council (AATAC) to expand the portfolio of branded products at AATAC’s member retailers including branded locations such as Circle K, 7-Eleven, Hess, Mobil, BP, Chevron, Sunoco and other gas stations, convenience stores and other retail outlets throughout the United States and Puerto Rico.
AATAC is a national association council of buying groups and trade associations integrated under one entity that spans over 80,000 C-Stores in the country. The group forms relationships with corporate suppliers for the benefit of the group, supports the various suppliers, hosts tradeshows and private meetings, and distributes newsletters and other communication to its member partners.
REACH Genetics, Inc. provides Full Spectrum Hemp extracted products (CBD) with Zero THC; this addition of accounts with AATAC retailers significantly strengthens brand presence specifically in the convenience channel.
About REACH Genetics, Inc.
Launched in October 2015, REACH Genetics, Inc. a US company, began as a consultancy firm and has evolved to include an international research and development partnership for Industrial Hemp. Its leadership team merges traditional business management with an outsourced team of scientists that focus on data collection and analysis of chemical, genetic and phenotypic profiles of hemp, allowing the company to create proprietary varieties of hemp that are targeted for specific uses for the emerging markets.
SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
Forward Looking Statements:
This communication shall not constitute an offer to sell or the solicitation of an offer to buy securities nor shall there be any sale of these securities in any state in which such solicitation or sale would be unlawful prior to registration or qualification of these securities under the laws of any such state.
This Press Release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These “forward-looking statements” that address activities, events or developments that Doyen Elements, Inc. expects, anticipates, or estimates may occur in the future. Generally forward-looking statements by words such as “may,” “will,” “would,” “could,” “continue,” “potential,” “anticipate,” “believe,” “plan,” “estimate,” “expect,” “intend” and other similar expressions. There are a numerous risks and uncertainties, both known and unknown, that could cause actual results to differ materially from the results implied by the forward-looking statements, which may include but are not limited to, business risks, general industry conditions and competition, general economic factors, governmental actions, legislative conditions, the impact of cannabis industry regulation, legislation in the United States and internationally and technological advances. REACH Genetics undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.